National People’s Congress Representative Chu Feng Visits HymonBio

National People’s Congress Representative Chu Feng visited HymonBio for research and in-depth understanding of the company’s technological innovation and industrial development in the field of precision medicine. Representative Chu Feng expressed great concern about the company’s breakthrough progress in the field of biotechnology, and learned in detail about the company’s research and development and application in the fields of pan-cancer early screening and precision diagnosis.

Representative Chu Feng fully affirmed the achievements of HymonBio in pan-cancer early screening. At the same time, he also listened to the difficulties and challenges encountered by the company in the medical device registration application process, including approval process, policy support and industry standards. Representative Chu Feng said that he would bring HymonBio’s suggestions and demands to the upcoming National People’s Congress, actively promote the optimization of relevant policies, and provide stronger support for the high-quality development of the biotechnology industry.

Ma Xiaojuan, co-founder and deputy general manager of HymonBio, warmly welcomed the visit of Chu Feng and thanked him for his support and guidance for the development of the company. In the future, HymonBio will continue to uphold the concept of “innovation-driven, science and technology for the people”, promote the continuous progress of the biotechnology field, and contribute to the cause of human health.